# A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures

> **NCT05076617** · PHASE3 · ENROLLING_BY_INVITATION · sponsor: **UCB Biopharma SRL** · enrollment: 300 (estimated)

## Conditions studied

- Stereotypical Prolonged Seizures

## Interventions

- **DRUG:** Staccato alprazolam

## Key facts

- **NCT ID:** NCT05076617
- **Lead sponsor:** UCB Biopharma SRL
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2022-02-03
- **Primary completion:** 2028-11-30
- **Final completion:** 2028-11-30
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05076617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05076617, "A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures". Retrieved via AI Analytics 2026-08-08 from https://api.ai-analytics.org/clinical/NCT05076617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*